NeuroOne Medical Technologies Corp

Research NeuroOne Medical Technologies Corp (NMTC) on Bullrun: market cap USD 18.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 18.80M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 9.10M-USD 3.61M-USD 2.92M56.5%-0.09USD 6.57MUSD 237.38KUSD 7.07M
FY2024USD 3.45M-USD 12.32M-USD 11.13M31.3%-0.46USD 1.46MUSD 341.51KUSD 822.01K
FY2023USD 1.95M-USD 11.86M-USD 13.27M23.4%-0.65USD 5.32MUSD 129.12KUSD 6.25M
FY2022USD 171.17K-USD 10.00M-USD 7.79M-41.4%-0.63USD 8.16MUSD 232.01KUSD 9.60M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 18.80Mn/an/an/a
20252025-12-31USD 38.23Mn/an/an/a
20242024-12-31USD 25.50M248.0n/an/a
20232023-12-29USD 37.86Mn/an/an/a
20222022-12-30USD 19.49Mn/an/an/a
20212021-12-31USD 31.40Mn/an/an/a

About NeuroOne Medical Technologies Corp

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is NeuroOne Medical Technologies Corp's market cap?

NeuroOne Medical Technologies Corp's market capitalization is USD 18.80M.

What does NeuroOne Medical Technologies Corp do?

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.